Close
Enter your
text here
Monthly Archives :

December 2025

Advancing Surgical Care for Pediatric Hip Dysplasia
 Advancing Surgical Care for Pediatric Hip Dysplasia 1024 575 Pam Georgiana
By: Pam Georgiana

A novel technique demonstrates safety, stability and reduced casting needs. For children with developmental dysplasia of the hip, open reduction surgery reliably restores the hip to the socket. However, recurrent instability, iatrogenic complications, residual dysplasia and prolonged casting can limit favorable outcomes. To improve these results, orthopedic surgeons at Nationwide Children’s Hospital have developed a…

Long-Term Kidney Complications Are Common Among Pediatric and Young Adult Cancer Survivors
 Long-Term Kidney Complications Are Common Among Pediatric and Young Adult Cancer Survivors 1024 683 Pam Georgiana
By: Pam Georgiana

Study reveals the need for improved surveillance and updated survivorship guidelines. As pediatric cancer survival rates continue to climb, focus is shifting to enhancing the long-term health of survivors. While treatments have become more precise, their delayed effects are not yet fully understood. A new study led by Diana Zepeda-Orozco, MD, principal investigator in the…

Watchful Waiting: The New Recommendation for Most Preterm Infants With PDA
 Watchful Waiting: The New Recommendation for Most Preterm Infants With PDA 1024 683 Abbie Miller
By: Abbie Miller

A study published in JAMA found that treating patent ductus arteriosus with medication did not help with disease management but was associated with higher mortality.   A new study from the Neonatal Research Network, published in JAMA, found that treating patent ductus arteriosus (PDA) in preterm infants with nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen at…

Setting the Stage the Next Era of Gene Therapy for Ultrarare Disease
 Setting the Stage the Next Era of Gene Therapy for Ultrarare Disease 1024 576 Abbie Miller
By: Abbie Miller

Researchers at Nationwide Children’s Hospital recently administered a novel gene therapy targeting SLC6A1, advancing precision medicine for children who previously could not be treated. Maxwell, age 8, made history this fall, when he received a bespoke gene therapy targeting his ultrarare disease. This wasn’t the first time he worked with the team at Nationwide Children’s…

3 Things to Know About Glomerular Disease
 3 Things to Know About Glomerular Disease 1024 683 Gina Vitale, PTA
By: Gina Vitale, PTA

Gabriel Cara Fuentes, MD, PhD, offers insights for physicians regarding pediatric glomerular disease treatment and referral. Gabriel Cara Fuentes, MD, PhD, a pediatric nephrologist and principal investigator at the Kidney and Urinary Tract Research Center at Nationwide Children’s Hospital, is focused on a translational approach to improving pediatric care and outcomes. Since arriving at Nationwide…

Expanding the Evidence for Cannabidiol in Focal Epilepsy
 Expanding the Evidence for Cannabidiol in Focal Epilepsy 1024 575 Pam Georgiana
By: Pam Georgiana
Young boy turned sideways in front of a dark background, with dark lighting and an illustration of his brain appearing in front of the side of his head

A multicenter study led by Nationwide Children’s Hospital demonstrates long-term efficacy and safety of Epidiolex® for treatment-resistant seizures. As global use of cannabidiol for seizure management increases, most research has targeted generalized epilepsy. This leaves a major evidence gap for patients with focal seizures and epilepsy. Anup D. Patel, MD, FAAN, FAES, FCNS, neurologist and…